These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11709743)

  • 1. [Cross-over comparison of the pharmacokinetics of estradiol during hormone replacement therapy with estradiol valerate or micronized estradiol].
    Wiegratz I; Fink T; Rohr UD; Lang E; Leukel P; Kuhl H
    Zentralbl Gynakol; 2001 Sep; 123(9):505-12. PubMed ID: 11709743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement in postmenopausal women: are we currently overdosing our patients?
    Tepper R; Goldberger S; Cohen I; Segal J; Yarkoni S; Fejgin M; Beyth Y
    Gynecol Obstet Invest; 1994; 38(2):113-16. PubMed ID: 7959337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS; Donath F; Blume HH
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
    Zimmermann H; Koytchev R; Mayer O; Börner A; Mellinger U; Breitbarth H
    Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
    Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF
    Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.
    Conner P; Söderqvist G; Skoog L; Gräser T; Walter F; Tani E; Carlström K; von Schoultz B
    Breast Cancer Res Treat; 2003 Mar; 78(2):159-65. PubMed ID: 12725416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral blood lymphocyte subpopulations of postmenopausal women with hormone replacement therapy].
    Höll M; Donat H; Weise W
    Zentralbl Gynakol; 2001 Sep; 123(9):543-5. PubMed ID: 11709749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative pharmacokinetic study of micronized estradiol valerate administered alone and in combination with medroxyprogesterone acetate in postmenopausal women.
    Saavedra I; León J; Prado J; Sánchez MP; López F; Gaete L
    Ther Drug Monit; 2004 Oct; 26(5):482-5. PubMed ID: 15385829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioidentical compounded hormones: a pharmacokinetic evaluation in a randomized clinical trial.
    Sood R; Warndahl RA; Schroeder DR; Singh RJ; Rhodes DJ; Wahner-Roedler D; Bahn RS; Shuster LT
    Maturitas; 2013 Apr; 74(4):375-82. PubMed ID: 23384975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
    Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
    Mueck AO; Seeger H; Gräser T; Oettel M; Lippert TH
    Horm Metab Res; 2001 Dec; 33(12):744-7. PubMed ID: 11753761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of hormone replacement therapy on the quality of life in postmenopausal women with hypertension].
    Czarnecka D; Klocek M; Betkowska-Korpała B; Jankowski P; Olszanecka A; Kawecka-Jaszcz K
    Przegl Lek; 2000; 57(7-8):397-401. PubMed ID: 11109313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence and relative bioavailability of three estradiol and norethisterone acetate-containing hormone replacement therapy tablets.
    Zdravkovic M; Müller M; Larsen S; Degenkolb J; Pabst G
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):41-6. PubMed ID: 11204938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.
    Scott RT; Ross B; Anderson C; Archer DF
    Obstet Gynecol; 1991 May; 77(5):758-64. PubMed ID: 2014092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol valerate/dienogest.
    Wellington K; Perry CM
    Drugs; 2002; 62(3):491-504; discussion 505-6. PubMed ID: 11827562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.